“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 30, 2020
Part III: Angling to Price-Gouge American Public on COVID-19 Treatments… Read More
© 2024 CSRXP- All Rights Reserved
Updates
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 29, 2020
Part II: Gaming the System to Undermine Competition at the Expense of American… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 28, 2020
Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic… Read More
TWO BIRDS OF A FEATHER: ASTRAZENECA TO ACQUIRE FELLOW PRICE-GOUGER ALEXION IN MULTI-BILLION DOLLAR DEAL
Dec 14, 2020
In case you missed it, Big Pharma giant AstraZeneca announced plans to acquire… Read More
CSRXP STATEMENT ON SELECTION OF XAVIER BECERRA FOR THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Dec 7, 2020
Campaign Looks Forward to Working with Becerra to Lower Drug Prices… Read More
CSRXP: BIG PHARMA MUST BE HELD ACCOUNTABLE FOR ESCALATING ASSAULT ON CRITICAL 340B PROGRAM
Dec 3, 2020
Novo Nordisk Becomes Latest Drug Company to Dodge Requirement to Provide… Read More
CSRxP: MISGUIDED REBATE RULE A BIG PHARMA BAILOUT PAID FOR BY AMERICAN SENIORS & TAXPAYERS
Nov 20, 2020
Rebate Rule Will Increase Premiums for Medicare Part D Beneficiaries… Read More
REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION
Nov 16, 2020
Administration Should Abandon Misguided Policy That Rewards Drug Companies’… Read More
CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS
Nov 9, 2020
Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB
Nov 5, 2020
Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020… Read More
BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI
Nov 5, 2020
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants… Read More
CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP
Oct 30, 2020
Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir… Read More